
Migraine Science
MRI Study Reveals Brain Differences in Patients with Migraine, Offering Hope for Better Diagnostics and Treatment
Posted on April 18 2024,
A recent study published in the journal Neurology has found interesting observations on the brain structure of people with migraine. The study compared MRI scans of 296 migraine patients to 155 healthy controls, analyzing cortical surface area, thickness, and volume.
The researchers found that migraine patients, especially those with chronic migraine, had reduced cortical surface area in the left anterior insula, a region involved in pain processing. They also discovered increased surface area in the right caudal anterior cingulate cortex (ACC) in chronic migraine, which correlated with monthly headache frequency. Furthermore, migraine without aura was associated with greater right caudal ACC surface area compared to controls.
No significant differences in cortical thickness or volume were found between migraine and control groups.
The study's findings have important implications for people with migraine. The distinct brain signatures observed in different migraine subtypes suggest that personalized diagnostics and therapies may be possible in the future.
The association between medication overuse/adaptation headache and brain structure changes also highlights the need for effective preventive treatments.
Finally, this is also further evidence that migraine is not “just in your head” as some therapy people we recently talked about like to claim. It is not fear-based, but real, anatomical, and functional changes occurring in the nervous system, including the brain.
Mon, Aug 10, 26
Gepants for Migraine: Atogepant & Rimegepant Evidence
A new review of 16 randomized trials breaks down how the gepants atogepant and rimegepant perform for migraine prevention and acute treatment. Here is what the evidence shows on efficacy,...
Read MoreMon, Aug 10, 26
Semaglutide (Ozempic, GLP-1) and Migraine: What a 189,000-Person Study Found
A nationwide Danish study of 189,392 adults found that starting weight-loss semaglutide was followed by a gradual 7% reduction in triptan use over 12 months. Here is what the findings...
Read MoreMon, Aug 03, 26
Blood Thinners for Migraine With a PFO: What a 1,000-Person Trial Found
A new BMJ randomized trial in 1,000 adults with migraine and a patent foramen ovale found rivaroxaban beat metoprolol for migraine prevention, with aspirin and clopidogrel close behind. Here is...
Read More




